Delivery Order SPE2DB20D3103-SPE2DB25FP2F9
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,259.60 delivery order on October 23, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with completion scheduled for October 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,853.05 on August 7, 2025, for the supply of Novolog 100 Unit/mL Flexpen 3mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. As a child order under a...
- The Defense Logistics Agency awarded a $3,891.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Novolog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of October 31, 2025. This delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,206.33 and a firm fixed-price structure. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract is set to be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,976.49 by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. The contract operates under firm fixed-price terms with an ultimate completion date of September 29, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is executed as a child contract under...
- The Defense Logistics Agency awarded a $27,329.09 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Novolog 100 Unit/ml FlexPen 3ml insulin pens. The contract, which is not set aside for any particular business category, utilizes firm fixed pricing and requires completion by August 18, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,027.17 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. The contract, issued on April 30, 2025, with an ultimate completion date of May 1, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This non-set-aside, competitively awarded contract has a ceiling value of $1,794.04 with a firm fixed price structure and an ultimate completion date of December 22, 2025. The delivery order will be fulfilled at AmerisourceBergen's Conshohocken facility and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,464.90 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This competitively awarded, firm fixed-price delivery order was issued on November 26, 2025, with an ultimate completion date of November 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,633.44 for NovoLog 100 Unit/ML FlexPen 3ML insulin pens on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-competitive, firm fixed-price delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP2F9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Novolog 100 Unit/ML FlexPen 3ML insulin pens, valued at $7,663.20. This is a firm fixed-price delivery order issued on June 18, 2025, with completion scheduled for June 20, 2025. The contract was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order supplies insulin products to support diabetes management across the Department of Defense healthcare system, consistent with AmerisourceBergen's established role as a key supplier of specialty and chronic disease medications to military personnel and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 6/18/25 |